EUR 2.77
(0.91%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 77.86 Million | 95.59 Million | 95.61 Million | 72.32 Million | 77.15 Million | 70.45 Million |
Net Income | 45.42 Million | 35.99 Million | 44.28 Million | 12.98 Million | 35.99 Million | 28.62 Million |
Depreciation & Amortization | 66.11 Million | 48.46 Million | 47.17 Million | 48.37 Million | 47.14 Million | 23.97 Million |
Deferred income taxes | -11.28 Million | 7.06 Million | -2.38 Million | 55 Thousand | -1 Million | -4.87 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -40.3 Million | -28.31 Million | -7.25 Million | -14 Million | -6.9 Million | 26.3 Million |
Other non-cash items | 184.28 Million | 39.45 Million | 11.41 Million | 24.96 Million | 925 Thousand | -8.45 Million |
Investing Cash Flow | -63.76 Million | -114.43 Million | -84.33 Million | -25.75 Million | -73.02 Million | -62.61 Million |
Investments in PPE | -52.71 Million | -38.69 Million | -31.26 Million | -25.71 Million | -28.07 Million | -24.28 Million |
Acquisitions | 2.54 Million | -969 Thousand | -2.38 Million | -7.45 Million | -20.84 Million | -36 Million |
Investment purchases | -79.76 Million | -89.46 Million | -79.5 Million | -20 Million | -36.21 Million | -6.58 Million |
Sales/Maturities of investments | 66.16 Million | 8.35 Million | 25.47 Million | 26.57 Million | 9.19 Million | 3.01 Million |
Other Investing Activities | 8.18 Million | 6.34 Million | 3.34 Million | 846 Thousand | 2.9 Million | 1.23 Million |
Financing Cash Flow | 28.92 Million | -49.77 Million | 4.75 Million | 53.76 Million | -69.2 Million | 60.32 Million |
Debt repayment | -77.92 Million | -20.89 Million | -36.14 Million | -3.57 Million | -58.39 Million | -59.08 Million |
Dividends payments | -14.74 Million | -13.53 Million | -3.98 Million | -12.66 Million | -594 Thousand | -129 Thousand |
Common Stock Repurchased | -8.39 Million | -27.41 Million | -23.25 Million | -16.95 Million | -10.72 Million | -615 Thousand |
Common Stock Issuance | -23.29 Million | - | 20.32 Million | - | 73 Thousand | - |
Other Financing Activities | 153.29 Million | 13.86 Million | 50 Million | 86.95 Million | 439 Thousand | 61.06 Million |
Accounts receivables | 25.74 Million | -137.8 Million | 24.02 Million | -51.79 Million | -28.68 Million | -377 Thousand |
Accounts payables | -16.15 Million | 164.39 Million | 14.77 Million | 40.16 Million | 14.97 Million | 19.11 Million |
Inventory | -43.72 Million | -14.18 Million | -24.32 Million | 638 Thousand | 13.72 Million | 5.04 Million |
Other working capital | -6.17 Million | -40.72 Million | -21.73 Million | -3.01 Million | -6.92 Million | 21.25 Million |
Cash at beginning of period | 182.38 Million | 254.2 Million | 237.62 Million | 141.54 Million | 205.57 Million | 138.16 Million |
Cash at end of period | 224.73 Million | 182.38 Million | 254.2 Million | 237.62 Million | 141.54 Million | 205.57 Million |
Capital Expenditure | -52.71 Million | -38.69 Million | -31.26 Million | -25.71 Million | -28.07 Million | -24.28 Million |
Effect of forex changes on cash | -645 Thousand | 1.3 Million | 550 Thousand | -4.25 Million | 1.04 Million | -390 Thousand |
Net cash flow / Change in cash | 42.34 Million | -71.82 Million | 16.57 Million | 96.08 Million | -64.02 Million | 67.41 Million |
Free Cash Flow | 25.15 Million | 56.9 Million | 64.34 Million | 46.6 Million | 49.08 Million | 46.17 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 8.97 Million | 7.3 Million | 21.67 Million | 45.42 Million | 10.49 Million | 23.75 Million |
Depreciation & Amortization | 30.72 Million | - | 35.05 Million | 66.11 Million | 17.52 Million | 31.06 Million |
Deferred income taxes | -3.07 Million | - | -10.3 Million | -11.28 Million | - | -985 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -35.02 Million | - | -52.15 Million | -40.3 Million | 4.15 Million | 11.85 Million |
Other non-cash items | -8.97 Million | -7.3 Million | 101.54 Million | 184.28 Million | -30.8 Million | 82.74 Million |
Investing Cash Flow | -82.22 Million | - | 15.25 Million | -63.76 Million | 7.62 Million | -79.02 Million |
Investments in PPE | -19.15 Million | - | -26.06 Million | -52.71 Million | -13.03 Million | -26.64 Million |
Acquisitions | -9.51 Million | - | 1.32 Million | 2.54 Million | -2.94 Million | 1.21 Million |
Investment purchases | -57.94 Million | - | 10.07 Million | -79.76 Million | - | -89.84 Million |
Sales/Maturities of investments | 4.39 Million | - | 29.91 Million | 66.16 Million | - | 36.25 Million |
Other Investing Activities | - | - | - | - | 23.6 Million | - |
Financing Cash Flow | 10.5 Million | - | 6.08 Million | 28.92 Million | 3.04 Million | 22.84 Million |
Debt repayment | -35.83 Million | - | -33 Million | -77.92 Million | - | -44.92 Million |
Dividends payments | -448 Thousand | - | -13.64 Million | -14.74 Million | -6.82 Million | -1.1 Million |
Common Stock Repurchased | -12.21 Million | - | - | -8.39 Million | - | -8.39 Million |
Common Stock Issuance | - | - | - | -23.29 Million | - | - |
Other Financing Activities | -12.66 Million | - | -2.55 Million | 153.29 Million | 9.86 Million | -12.58 Million |
Accounts receivables | -23.1 Million | - | 58.11 Million | 25.74 Million | 29.05 Million | -32.37 Million |
Accounts payables | 353 Thousand | - | -60.46 Million | -16.15 Million | - | 44.31 Million |
Inventory | -640 Thousand | - | -20.61 Million | -43.72 Million | -10.3 Million | -23.1 Million |
Other working capital | -11.62 Million | - | -29.19 Million | -6.17 Million | -14.59 Million | 23.02 Million |
Cash at beginning of period | 224.73 Million | - | 203.25 Million | 182.38 Million | - | 182.38 Million |
Cash at end of period | 164.09 Million | - | 224.73 Million | 224.73 Million | 11.71 Million | 203.25 Million |
Capital Expenditure | -19.15 Million | - | -26.06 Million | -52.71 Million | -13.03 Million | -26.64 Million |
Effect of forex changes on cash | - | - | -2.59 Million | -645 Thousand | -322.5 Thousand | 1.91 Million |
Net cash flow / Change in cash | -60.64 Million | - | 21.48 Million | 42.34 Million | 11.71 Million | 20.86 Million |
Free Cash Flow | -8.2 Million | - | -23.32 Million | 25.15 Million | -11.66 Million | 48.47 Million |
MAXHEALTH
PHVS
TI
002870
ULVR
RY4C